Ads
related to: best rheumatoid arthritis treatment- Supporting Patients
Find Support For Your Patients.
Enroll Today
- Downloadable Resources
Get Resources For Your Office
And For Your Patients Today
- Treatment Savings
As Little As $0 Copay Per Month
See If Your Patients Are Eligible
- Specialty Pharmacies
Learn More About
In-Network Specialty Pharmacies
- Supporting Patients
Search results
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 2 days agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with ...
What Is the Dividend Payout for AbbVie Stock? | The Motley Fool
The Motley Fool· 1 day agoMany investors hold a stake in AbbVie (ABBV 0.33%) because it offers exposure to the healthcare sector. AbbVie is also a quality dividend stock. AbbVie is the company behind cancer-fighting ...
New Clinical Guidance for Sjögren-Related Neuropathy
Medscape· 7 days agoNew guidelines to manage peripheral neuropathy related to Sjogren disease have been developed by a multidisciplinary team of physicians from across...
Are you searching for a natural solution to arthritis pain? - Times Leader
Times Leader· 3 days agoPeople who suffer from arthritis pain frequently resort to costly surgery, steroid injections, and prescription medications to alleviate their symptoms. Arthritis ...
Serum Metabolome Identifies Cancer in Rheumatic Disease
Medscape· 5 days agoA recent study revealed that alterations in the serum metabolome indicated the presence of...
Amgen Inc. (AMGN) To Go Ex-Dividend on May 16th
ETF DAILY NEWS· 16 hours agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) announced a quarterly dividend on Wednesday, March 6th, RTT News reports. This represents a $9.00 annualized dividend and a dividend yield of 2.92% ...
AbbVie widens search for next hit drug with psychiatric deal worth up to $2B
Crain s Chicago Business· 1 day agoAbbVie, which already has a growing psychiatry portfolio, is paying Gilgamesh $65 million upfront and as much as $1.95 billion in aggregate option fees and milestones in the future. Under the ...
EU researchers are taking fresh approaches to understanding immune-system disorders for more...
Medical Xpress· 4 days agoThe study is part of a research project examining links between immune-system illnesses and external...
Is hay fever causing JOINT pain? The 7 health problems triggered by pollen bomb
The US Sun· 1 day agoWHILE the warm weather heralds picnics and ploughman’s for many, it can spell misery for the...
Noxopharm scales up production of lupus drug SOF-SKN™ to GLP standards
Proactive Investors· 1 day agoNoxopharm Ltd (ASX:NOX, OTC:NOXOF) has reached a major drug development milestone in scaling up...